LENZ
LENZ Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -9.1% ·
share flow +3.8% ·
net new positions -10.0%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 61 | 0 | 17.94M | $101.96M | +9 | −9 |
| Q1 2026 | 63 | -5 | 16.96M | $155.30M | +10 | −15 |
| Q4 2025 | 68 | +1 | 17.01M | $272.30M | +3 | −2 |
| Q3 2025 | 14 | +1 | 5.86M | $273.11M | +1 | — |
| Q2 2025 | 10 | -1 | 5.40M | $158.18M | — | −1 |
| Q1 2025 | 8 | 0 | 2.39M | $61.53M | +2 | −2 |
| Q4 2024 | 8 | +1 | 2.51M | $72.56M | +1 | — |
| Q3 2024 | 6 | +1 | 1.75M | $41.57M | +2 | −1 |
| Q2 2024 | 5 | — | 1.34M | $23.21M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 1.43M | — | $41.99M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passive) | 1.43M | — | $41.99M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 1.43M | — | $41.99M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 1.43M | — | $41.99M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 1.43M | — | $41.99M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 1.43M | — | $41.99M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 1.43M | — | $41.99M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 1.43M | — | $41.99M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 1.43M | — | $41.99M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 1.43M | — | $41.99M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passive) | 1.43M | — | $41.99M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passive) | 1.43M | — | $41.99M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passive) | 1.29M | — | $37.84M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passive) | 1.29M | — | $37.84M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passive) | 1.29M | — | $37.84M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passive) | 1.29M | — | $37.84M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passive) | 1.29M | — | $37.84M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 1.12M | +108.8% | $32.91M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 618.14K | -27.5% | $18.12M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passive) | 416.12K | +15.5% | $12.20M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Geode Capital Management ✦ (passive) | 416.12K | +15.5% | $12.20M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | State Street Global Advisors ✦ (passive) | 375.73K | +30.8% | $11.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Fidelity (FMR) ✦ | 81.64K | — | $2.39M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Wellington Management ✦ | 34.83K | +14.2% | $1.02M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 25 | Wellington Management ✦ | 34.83K | +14.2% | $1.02M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 26 | Wellington Management ✦ | 34.83K | +14.2% | $1.02M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 14.93K | -95.1% | $438,000 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 28 | Citadel Advisors ✦ | 9.04K | -5.8% | $264,874 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Two Sigma Investments | $213,959 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 143 holders, 33.15M shares, $300.01M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.